You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
納微科技(688690.SH):正式發佈Truesynt™核酸合成系統首款新產品-STS0100寡核苷酸合成儀系統
格隆匯 03-12 21:53

格隆匯3月12日丨納微科技(688690.SH)公佈,公司2023年3月10日正式公開發布Truesynt核酸合成系統首款新產品-STS0100寡核苷酸合成儀系統。該產品是由公司控股子公司蘇州賽譜儀器有限公司研發,是一套實驗室級別的、全自動的亞磷酰胺法寡核苷酸合成儀。

公司致力於從合成儀、固相合成載體、純化設備、純化填料到分析色譜柱構建一個完整的、滿足核酸藥物開發到商業化生產的整體解決方案,新產品STS0100核酸合成儀是公司在核酸合成環節的第一款產品,有助於公司為生物醫藥客户提供更具競爭力的服務方案,對公司的發展將產生積極的影響。

公司新產品STS0100核酸合成儀應用於核酸藥物實驗室級的合成環節,實現大批量銷售尚需較長時間的市場推廣和應用技術服務投入,存在未來市場推廣與客户開拓不及預期的風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account